These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2020612)

  • 1. Dose effectiveness and safety of butorphanol in acute migraine headache.
    Elenbaas RM; Iacono CU; Koellner KJ; Pribble JP; Gratton M; Racz G; Evens RP
    Pharmacotherapy; 1991; 11(1):56-63. PubMed ID: 2020612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine.
    Goldstein J; Gawel MJ; Winner P; Diamond S; Reich L; Davidson WJ; Sussman NM
    Headache; 1998; 38(7):516-22. PubMed ID: 15613167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of transnasal butorphanol tartrate in postepisiotomy pain: a model to assess analgesia.
    Joyce TH; Kubicek MF; Skjonsby BS; Jones MM
    Clin Ther; 1993; 15(1):160-7. PubMed ID: 8458045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
    Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
    Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery.
    Stoker DG; Reber KR; Waltzman LS; Ernst C; Hamilton D; Gawarecki D; Mermelstein F; McNicol E; Wright C; Carr DB
    Pain Med; 2008; 9(1):3-12. PubMed ID: 18254761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
    Stillman MJ; Zajac D; Rybicki LA
    Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
    Landy SH
    Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urological applications of butorphanol tartrate: postoperative pain and renal colic.
    Henry HH
    Acute Care; 1988; 12 Suppl 1():22-30. PubMed ID: 3344597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transnasal butorphanol in the treatment of acute migraine.
    Hoffert MJ; Couch JR; Diamond S; Elkind AH; Goldstein J; Kohlerman NJ; Saper JR; Solomon S
    Headache; 1995 Feb; 35(2):65-9. PubMed ID: 7737863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
    Zuniga JR; Ibanez C; Kozacko M
    J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.